Clinical Trials Directory

Trials / Unknown

UnknownNCT03927807

Oral Misoprostol Solution in Labor Induction

A Comparison of the Efficacy and Safety of Repetitive Hourly Dose of Oral Misoprostol and Two Hourly Dose Oral Regimens for Cervical Ripening and Labor Induction

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This study compares safety and efficacy between repetitive hourly dose of oral misoprostol and two hourly dose oral regimens for cervical ripening and labor induction.

Detailed description

Misoprostol is an effective agent for the induction of labor.existing guidelines recommend oral misoprostol solution every two hours.However,more research is required to optimize the use of oral misoprostol solution for labor induction.The current study is to compare efficacy and safety of repetitive hourly dose of oral misoprostol solution with two hourly dose of oral misoprostol solution for cervical ripening and labor induction.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostolThis study will include 150 pregnant women who fulfill the inclusion criteria and will be subdivided in two groups. Group1 will receive repetitive hourly dose of oral misoprostol solution equal to 10 microgram up to 12 doses or regular uterine activity. Group2 will receive oral misoprostol solution every two hours as 20 microgram up to 6 doses or regular uterine activity.

Timeline

Start date
2019-03-18
Primary completion
2019-12-18
Completion
2020-01-18
First posted
2019-04-25
Last updated
2019-04-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03927807. Inclusion in this directory is not an endorsement.

Oral Misoprostol Solution in Labor Induction (NCT03927807) · Clinical Trials Directory